SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-160511
Filing Date
2021-05-13
Accepted
2021-05-13 16:17:36
Documents
3
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d355932d8k.htm 8-K 18282
2 EX-99.1 d355932dex991.htm EX-99.1 49803
3 GRAPHIC g355932sil01.jpg GRAPHIC 6782
  Complete submission text file 0001193125-21-160511.txt   78698
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 21919878
SIC: 2834 Pharmaceutical Preparations